Stockreport

Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF 1 data for its HDAC6 inhibitor TN-301 in Duchenne muscular dystrophy and cardiomyopathy, alongside a new research collaboration with Alnylam Pharmaceuticals in cardiovas [Read more]